Similarly, we report here that, under mitochondrial stress conditions, loss of GFRAL leads to a partial recovery of lean and fat mass, indicating that GFRAL signaling might be instrumental in the development of a lean cachectic phenotype under conditions of mitochondrial dysfunction such as mitochondrial disease and therefore a potential target for therapeutic interventions in these patients. This evidence concerns the gene GFRAL and mitochondrial disease.